Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
An MR Brain Images Classifier System via Particle Swarm Optimization and Kernel Support Vector Machine.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
THE CLINICAL SPECTRUM OF MICROCYSTIC MACULAR OEDEMA.
The progress of cognitive decline in newly diagnosed MS patients.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Saffold cardiovirus and multiple sclerosis: no evidence for an association.
Psychiatric disturbances in radiologically isolated syndrome.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
Reduced spontaneous sympathetic nerve activity in multiple sclerosis patients.
Epstein-barr virus: the path from association to causality for a ubiquitous human pathogen.
Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model.
Pages
« first
‹ previous
…
478
479
480
481
482
483
484
485
486
…
next ›
last »